Zhou, Ying
Zhang, Jing
He, Yang
Wang, Yun
Li, Bing
Zhu, Tengfei
Su, Yanjun
Article History
Received: 13 June 2024
Accepted: 16 February 2025
First Online: 20 March 2025
Declarations
:
: This study was approved by the Institutional Review Board of Tianjin Cancer Hospital. Informed consent was obtained from all patients.
: Consent for publication was obtained from all patients.
: BL and TZ are employees of Burning Rock Biotech, Guangzhou, China. Other authors declare that they have no competing interests.